In this episode, host Shikha Jain, MD, speaks with James Hamrick, MD, and Sanjeev Kumar about the value of biomarker testing and precision oncology, personal journeys with patient advocacy and more. • Welcome to another exciting episode of Oncology Overdrive 1:05 • About Kumar 1:20 • About Hamrick 1:52 • The interview 2:30 • Sanjeev, can you tell us about how you got involved in oncology and immunology? 2:59 • James, how did you get into this space and start working with Caris Life Sciences? 7:15 • Sanjeev, how did your mother’s experience unfold, and how did you incorporate your personal knowledge help advocate and navigate throughout the situation? 12:00 • Hamrick and Kumar on the importance of patient advocacy. 17:44 • Jain, Hamrick and Kumar on the impact precision oncology can have on personalized cancer care. 23:57 • How do we make current innovations available to everyone? How can we help advocate for patients in rural areas? 28:33 • Hamrick on how precision oncology helps support decision-making for physicians and community oncologists. 35:13 • Jain, Hamrick and Kumar on the art and practice of medicine. 40:57 • If someone could only listen to the last minute of this episode, what would you want listeners to take away? 41:53 • How to contact Kumar 44:13 • How to contact Hamrick 44:34 • Thanks for listening 45:14 James Hamrick, MD, MPH, is the chairman of the Caris Precision Oncology Alliance™ (Caris POA) at Caris Life Sciences.

Sanjeev Kumar is chairman and CEO of the Gallbladder Cancer Foundation, and is a biotech manufacturing leader with a background in immunology from UC Berkeley.

We’d love to hear from you! Send your comments/questions to Dr. Jain at [email protected]. Follow Healio on X and LinkedIn: @HemOncToday and https://www.linkedin.com/company/hemonctoday/. Follow Dr. Jain on X: @ShikhaJainMD. Kumar can be reached via email at [email protected], or at the Gallbladder Cancer Foundation website. Hamrick can be reached at the Caris Life Sciences website.

Disclosures: Jain and Kumar report no relevant financial disclosures. Hamrick reports being an employee of Caris Life Sciences and an advisor to Community Oncology Partners LLC.